Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Eucure (Beijing) Biopharma Co., Ltd
Scientific Title
A Multicenter, Open-Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Combination of YH003, YH001 and Pembrolizumab in Subjects With Advanced Solid Tumors